DUX4 and neoplasm: Consistent with this notion, inhibition of p300 activity in CDS cells by genetic and pharmacological approaches, recapitulated the transcriptional changes observed upon CIC-DUX4 depletion, and resulted in tumor growth decreases in vitro and in vivo.